Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tobias Jagomast"'
Autor:
Christiane Kuempers, Tobias Jagomast, Carsten Heidel, Finn-Ole Paulsen, Sabine Bohnet, Stefanie Schierholz, Eva Dreyer, Jutta Kirfel, Sven Perner
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimNon-small cell lung cancer (NSCLC) remains the leading cause of cancer-related death globally despite promising progress of personalized therapy approaches. Cyclin-dependent kinase 7 (CDK7) is a kinase involved in transcription, overexpressed in a
Externí odkaz:
https://doaj.org/article/71d17770ef834831a4c56252dcf835ed
Autor:
Tobias Jagomast, Theresa Mohr, Paul Niklas Axt, Kai Mortensen, Folke Brinkmann, Markus Weckmann, Gordon Ring, Michael Reppel, Daniel Drömann, Klaas F. Franzen
Publikováno v:
Journal of Functional Morphology and Kinesiology, Vol 8, Iss 3, p 101 (2023)
Cardiovascular health at a young age has implications for preventing cardiovascular disease, and it is associated with improved physical and cognitive performance during the aging process. Sports are well known to prevent cardiovascular disease; howe
Externí odkaz:
https://doaj.org/article/12de5eaa31574d10bfa2440bb570ae45
Autor:
Christiane Kuempers, Tobias Jagomast, Rosemarie Krupar, Finn-Ole Paulsen, Carsten Heidel, Julika Ribbat-Idel, Christian Idel, Bruno Märkl, Martin Anlauf, Sabina Berezowska, Markus Tiemann, Hans Bösmüller, Falko Fend, Barbara Kalsdorf, Sabine Bohnet, Eva Dreyer, Verena Sailer, Jutta Kirfel, Sven Perner
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Rovalpituzumab tesirine (Rova-T), an antibody-drug conjugate directed against Delta-like protein 3 (DLL3), is under development for patients with small cell lung cancer (SCLC). DLL3 is expressed on the majority of SCLC samples. Because SCLC is rarely
Externí odkaz:
https://doaj.org/article/2f2a6251c4574098908108fee406f2a3
Autor:
Louisa Proppe, Tobias Jagomast, Julika Ribbat-Idel, Sophie Beume, Georgios Gitas, Franziska Hemptenmacher, Achim Rody, Sven Perner, Lars Hanker
Publikováno v:
E-Posters.
Autor:
Louisa Proppe, Tobias Jagomast, Julika Ribbat-Idel, Sophie Beume, Georgios Gitas, Franziska Hemptenmacher, Achim Rody, Sven Perner, Lars Christian Hanker
Publikováno v:
Endometrial cancer.
Autor:
Amelie von Bernuth, Julika Ribbat-Idel, Luise Klapper, Tobias Jagomast, Dirk Rades, Anke Leichtle, Ralph Pries, Karl-Ludwig Bruchhage, Sven Perner, Anne Offermann, Verena Sailer, Christian Idel
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 6; Pages: 5140
Patients with head and neck squamous cell carcinoma (HNSCC) continue to have a rather poor prognosis. Treatment-related comorbidities have negative impacts on their quality of life. TRIM21 is a cytosolic E3 ubiquitin ligase that was initially describ
Autor:
Luise Klapper, Christian Idel, Patrick Kuppler, Tobias Jagomast, Amelie von Bernuth, Karl-Ludwig Bruchhage, Dirk Rades, Anne Offermann, Jutta Kirfel, Sven Perner, Julika Ribbat-Idel
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 6; Pages: 991
Background: Head and neck squamous cell carcinomas (HNSCCs) are among the most common cancers in humans worldwide and have a rather poor prognosis. TRIM24 has various intracellular functions and was identified in other cancer entities as a poor progn
Autor:
Justus Bottner, Julika Ribbat-Idel, Luise Klapper, Tobias Jagomast, Anna-Lena Lemster, Sven Perner, Christian Idel, Jutta Kirfel
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 5075
Head and neck squamous cell carcinomas (HNSCC) are among the most common cancers worldwide and are associated with a poor prognosis for patients. Among HNSCC, those originating in the hypopharynx have the worst prognosis. The histone demethylase LSD1
Autor:
Tobias Jagomast, Christian Idel, Luise Klapper, Patrick Kuppler, Anne Offermann, Eva Dreyer, Karl-Ludwig Bruchhage, Julika Ribbat-Idel, Sven Perner
Publikováno v:
Cancers, Vol 14, Iss 492, p 492 (2022)
Cancers; Volume 14; Issue 3; Pages: 492
Cancers; Volume 14; Issue 3; Pages: 492
HNSCC is the sixth most common cancer worldwide and the prognosis is still poor. Here, we investigated the prognostic implications of CDK7 and pMED1. Both proteins affect transcription, and their expression is altered throughout different tumor entit